2018年全球食管癌与胃癌按组织学类型和亚部位的疾病负担
研究基于人群癌症登记数据,按国家、性别和年龄组计算食管腺癌、食管鳞癌、贲门胃癌和非贲门胃癌的比例,并应用于GLOBOCAN 2018估算病例数。2018年全球估计新发食管癌572 000例(食管腺癌85 000例,食管鳞癌482 000例)、胃癌1.03百万例(贲门胃癌181 000例,非贲门胃癌853 000例);食管鳞癌、贲门胃癌和非贲门胃癌发病率以东亚最高,食管腺癌以北欧最高。
要点
- 2018年全球估计新发食管癌572 000例,其中食管腺癌85 000例、食管鳞癌482 000例。
- 2018年全球估计新发胃癌1.03百万例,其中贲门胃癌181 000例、非贲门胃癌853 000例。
- 食管鳞癌、贲门胃癌和非贲门胃癌发病率以东亚最高,食管腺癌发病率以北欧最高。
核心结论
- 这些更新的全球食管癌和胃癌按亚型及部位负担估计提示流行病学模式正在转变。
- 该工作将作为政策制定的基石,并有助于制定适当的癌症控制策略。
研究设计与样本
- 利用基于人群的癌症登记数据,按国家、性别和年龄组计算食管腺癌和食管鳞癌占全部食管癌的比例,以及贲门胃癌和非贲门胃癌占全部胃癌的比例。
- 将上述比例应用于GLOBOCAN 2018的食管癌和胃癌估计病例数,并计算年龄标化发病率(ASR)。
主要发现
- 2018年全球估计新发食管癌572 000例,其中食管腺癌85 000例(ASR 0.9/10万,两性合计),食管鳞癌482 000例(ASR 5.3)。
- 2018年全球估计新发胃癌1.03百万例,其中贲门胃癌181 000例(ASR 2.0),非贲门胃癌853 000例(ASR 9.2)。
- 食管鳞癌、贲门胃癌和非贲门胃癌发病率最高的地区为东亚(ASR分别为11.1、4.4和17.9),食管腺癌发病率最高的地区为北欧(ASR 3.5)。
- 全球范围内食管鳞癌和非贲门胃癌仍分别是食管癌和胃癌最常见的类型,但在越来越多的高收入国家,食管腺癌发病率超过食管鳞癌。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To provide updated estimates of the global burden of oesophageal and gastric cancer by subsite and type. METHODS: Using data from population-based cancer registries, proportions of oesophageal adenocarcinoma (OAC) and squamous cell carcinoma (OSCC) out of all oesophageal as well as cardia gastric cancer (CGC) and non-CGC (NCGC) out of all gastric cancer cases were computed by country, sex and age group. Proportions were subsequently applied to the estimated numbers of oesophageal and gastric cancer cases from GLOBOCAN 2018. Age-standardised incidence rates (ASR) were calculated. RESULTS: In 2018, there were an estimated 572 000 new cases of oesophageal cancer worldwide, 85 000 OACs (ASR 0.9 per 100 000, both sexes combined) and 482 000 OSCCs (ASR 5.3). Out of 1.03 million gastric cancers, there were an estimated 181 000 cases of CGC (ASR 2.0) and 853 000 cases of NCGC (ASR 9.2). While the highest incidence rates of OSCC, CGC and NCGC were observed in Eastern Asia (ASRs 11.1, 4.4 and 17.9, respectively), rates of OAC were highest in Northern Europe (ASR 3.5). While globally OSCC and NCGC remain the most common types of oesophageal and gastric cancer, respectively, rates of OAC exceed those of OSCC in an increasing number of high-income countries. CONCLUSIONS: These updated estimates of the global burden of oesophageal and gastric cancer by subtype and site suggest an ongoing transition in epidemiological patterns. This work will serve as a cornerstone for policy-making and will aid in developing appropriate cancer control strategies.
引用
- Arnold M, Ferlay J, van Berge Henegouwen MI, et al. Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut. 2020. PMID: 32606208. doi:10.1136/gutjnl-2020-321600
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。